STRAIGHT START ANTAGONIST PROTOCOL HAS SIMILAR OUTCOMES COMPARED TO PRETREATMENT ORAL CONTRACEPTIVE FOR ELECTIVE OOCYTE CRYOPRESERVATION IN PATIENTS WITH LOW ANTI-MULLERIAN HORMONE (AMH)